TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB91565

Peptide_Name

MAP-04-04

Activity

Antibacterial Anticancer Toxicity

Activity_category_statistics

Anti-infective peptides Cancer-related peptides Toxicity and safety peptides

Database_Source

AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF

Sequence_Type

standard

Has_Modification No

Description A 11-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.

Modification

C-terminal: Amidation

Sequence

KRLRRVWRRWR-NH2

FASTA

>TPDB91565|Antibacterial;Anticancer;Toxicity|length=11
KRLRRVWRRWR-NH2

Formula C75H126N32O12

Absent Amino Acids ANDCEQGHIMFPSTY

Common Amino Acids R

Mass 1668.03

PI 13.10

Basic Residues 7

Acidic Residues 0

Hydrophobic Residues 4

Net Charge +7

Boman Index 1.66

Hydrophobicity -2.245

Aliphatic Index 61.82

Half Life

Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min

Extinction Coefficient Cystines 11000

Absorbance 280nm 659.46

Polar Residues 0

number

0

A

6

R

0

N

0

D

0

C

0

E

0

Q

0

G

0

H

0

I

1

L

1

K

0

M

0

F

0

P

0

S

0

T

2

W

0

Y

1

V

Amino Acid Distribution

A: 0 R: 6 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 1

Length

11

Formula

C75H126N32O12

Mass

1668.03

PI

13.10

Net Charge

+7

Boman Index

1.66

Hydrophobicity

-2.245

C_terminal_Modification

Amidation

Chirality

L

Linear_or_Cyclic

Linear

N_terminal_Modification

Free

Nature

Antimicrobial

Origin

Analogs of Ixosin-B amide

Evidence 1 Activity

Activity

Activity Endpoint Cell viability

Activity Raw

Cell viability >80% at 50 µM

Detail Source Activity Anticancer

Activity Measurement >80 % at 50 µM

Target

Cancer Type Breast Cancer

Cell Line MCF-7

Tissue Affected Breast

Assay & Model

Assay MTT/MTS assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2013

Other

Source Activity Label	Source Definition
Anticancer	CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.

Evidence 2 Activity

Activity

Activity Endpoint Cell viability

Activity Raw

Cell viability >80% at 75 µM

Detail Source Activity Anticancer

Activity Measurement >80 % at 75 µM

Target

Cancer Type Breast Cancer

Cell Line MCF-7

Tissue Affected Breast

Assay & Model

Assay MTT/MTS assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2013

Evidence 3 Activity

Activity

Activity Endpoint Cell viability

Activity Raw

Cell viability >80% at 100 µM

Detail Source Activity Anticancer

Activity Measurement >80 % at 100 µM

Target

Cancer Type Breast Cancer

Cell Line MCF-7

Tissue Affected Breast

Assay & Model

Assay MTT/MTS assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2013